Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Hepion Pharmaceuticals Inc (HEPA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Hepion Pharmaceuticals's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.621 -0.029    -4.42%
13:15:32 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
ISIN:  US4268971045 
CUSIP:  426897104
  • Volume: 69,772
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.621 - 0.693
Hepion Pharmaceuticals 0.621 -0.029 -4.42%
IndustryPharmaceuticals
SectorHealthcare
Employees

20

Equity Type

ORD

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development of drug therapy for treatment of chronic liver diseases. This therapeutic approach targets fibrosis, inflammation, and the treatment hepatocellular carcinoma (HCC) associated with non-alcoholic steatohepatitis (NASH), viral hepatitis and other liver diseases. The Company's cyclophilin inhibitor, Rencofilstat (formerly CRV431), is developed to offer benefits to address multiple complex pathologies relate to advanced liver disease. Rencofilstat is a pan cyclophilininhibitor that targets multiple pathologic pathways involved in the progression of liver disease. It provides an artificial intelligence (AI) tool, AI-POWR, that allows the selection of novel drug targets, biomarkers, and appropriate patient populations. The components of AI-POWR include access to publicly available databases, and in-house genomic and multi-omic big.

Contact Information

Top Executives

Name Age Since Title
Timothy M. Block 66 2013 Independent Director
Arnold S. Lippa 74 2015 Independent Director
Fabien Zoulim - 2016 Member of Scientific Advisory Board
Philippe Gallay - 2016 Member of Scientific Advisory Board
Jörg Petersen - 2016 Member of Scientific Advisory Board
Jordan Feld - 2016 Member of Scientific Advisory Board
Robert T. Foster 63 2016 President, CEO & Director
Petrus Wijngaard 58 2020 Independent Director
Gary S. Jacob 74 2013 Independent Chairman of the Board
Carol L. Brosgart 69 2015 Chairperson of Scientific Advisory Board
John Patrick Brancaccio 73 2013 Independent Director
Jin-Lin Hou - 2018 Member of Scientific Advisory Board
Lik Yuen Chan 53 2018 Member of Scientific Advisory Board
Stephen A. Harrison - 2019 Member of Scientific Advisory Board & Consultant Medical Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

HEPA Comments

Write your thoughts about Hepion Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
stats con chris
stats con chris Jan 18, 2022 5:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1.05 is quite delicious :)
Serkan Demir
Serkan Demir Jul 26, 2021 3:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why is it showing 0.627? This stock closed at 1.59.
Hoss Cartwright
Hoss Apr 29, 2021 1:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Another offering up for vote, bad news
stats con chris
stats con chris Apr 25, 2021 6:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hepion was supposed to release treatment results in February and they never did. I suggest to newcomers...don't invest here. They lost credibility by missing deadlines. Moreover, investors bought at 2.00 and they are losing. Just wait for news to come in its website then you are welcome to come. Daytraders are likely winning because the oscillations here are so rewarding if you focus on profiting from the continous downtrend, don't wait for miracles in the long term until you have solid news. Cheers
stats con chris
stats con chris Mar 05, 2021 10:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Be ready to buy at 1 USD :D....enjoy the ride
stats con chris
stats con chris Mar 04, 2021 1:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Poor private company that bought shares at 2.00. They must be regreting. Now I buy at a lower price :). 1.7 is quite delicious. even if it drops to 1 due to the global crisis...is an amazing value for the long run...
John Walton
John Walton Mar 04, 2021 1:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This comment didn't age well..
John Walton
John Walton Mar 03, 2021 8:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I like the stock!
JOHN AH
JOHN AH Feb 23, 2021 6:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why -20% in Pre Market?
András Lakatos
András Lakatos Feb 17, 2021 7:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buying oppurtinity now, after the offering
Giuseppe Giannachi
Giuseppe Giannachi Feb 16, 2021 9:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Wow... Big Red... Cinnamon.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email